IN THE NEWSMariMed Inc: U.S. Pot Stock Up 135% in 2021 But Still Undervalued

May 28, 2021by MariMed Team
https://marimedinc.com/wp-content/uploads/2021/05/Untitled-design-2021-05-28T113530.425-1280x720.jpg

This article originally appeared in Profit Confidentialto see full article click here.

MariMed Stock Bullish on Record Q1 Results

Multistate operator MariMed Inc (OTCMKTS:MRMD) is one of the most compelling, undervalued cannabis stocks out there. And for good reason. MRMD stock has been on a tear since the company reported great third-quarter results in November 2020. And that stellar momentum has carried into 2021.

As of this writing, MariMed stock is up by:

  • 423% year-over-year
  • 135% year-to-date
  • 215 over the last six months
  • 215% over the last three months
  • 31% over the last five trading days.

Despite these eye-watering gains, MRMD stock still has a lot of room to run over the coming quarters and years—especially once recreational marijuana becomes legal at the federal level.

….. continued in full article at Profit Confidential 

 

All trademarks and service marks are the property of their respective owners.

Copyright © 2021 MariMed Inc. All rights reserved.